XML 61 R48.htm IDEA: XBRL DOCUMENT
v3.3.1.900

ACQUISITIONS AND PRO FORMA RESULTS (Schedule of Assets Acquired and Liabilities Assumed) (Details) - USD ($) $ in Thousands |  |  |  |  | 12 Months Ended |
--- | --- | --- | --- | --- | --- | ---
Oct. 02, 2015 | Dec. 05, 2014 | Oct. 27, 2014 | Jan. 24, 2013 | Dec. 31, 2015 | Dec. 31, 2014 | Jan. 15, 2014
Business Acquisition [Line Items] |  |  |  |  |  |  |
Goodwill |  |  |  |  | $ 512,389 | $ 363,479 |
TEI Biosciences Inc and TEI Medical Inc. |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Cash |  |  |  |  | 1,241 |  |
Accounts receivable, net |  |  |  |  | 9,011 |  |
Inventory |  |  |  |  | 23,223 |  |
Property, plant, and equipment |  |  |  |  | 2,027 |  |
Income tax receivable |  |  |  |  | 5,135 |  |
Other current assets |  |  |  |  | 2,670 |  |
Goodwill |  |  |  |  | 147,878 |  |
Total assets acquired |  |  |  |  | 409,999 |  |
Accrued expenses and other liabilities |  |  |  |  | 9,732 |  |
Deferred tax liabilities |  |  |  |  | 87,908 |  |
Other non-current liabilities |  |  |  |  | 0 |  |
Net assets acquired |  |  |  |  | 312,359 |  |
TEI Biosciences Inc and TEI Medical Inc. | Developed Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Intangible assets |  |  |  |  | 167,400 |  |
TEI Biosciences Inc and TEI Medical Inc. | Contractual Relationships |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Intangible assets |  |  |  |  | 51,345 |  |
TEI Biosciences Inc and TEI Medical Inc. | Leasehold interest |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Intangible assets |  |  |  |  | 69 |  |
Metasurg |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Payments to Acquire Businesses, Gross |  | $ 26,500 |  |  |  |  |
Inventory |  |  |  |  | 4,800 |  |
Property, plant, and equipment |  |  |  |  | 1,246 |  |
Goodwill |  |  |  |  | 732 |  |
Net assets acquired |  |  |  |  | 27,558 |  |
Metasurg | Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Intangible assets |  |  |  |  | 20,590 |  |
Medtronic MicroFrance |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Payments to Acquire Businesses, Gross |  |  | $ 61,600 |  |  |  |
Cash |  |  |  |  |  | 2,195 |
Inventory |  |  |  |  |  | 3,155 |
Property, plant, and equipment |  |  |  |  |  | 3,675 |
Other current assets |  |  |  |  |  | 5,025 |
Goodwill |  |  |  |  |  | 16,607 |
Total assets acquired |  |  |  |  |  | 65,977 |
Prepaid expenses |  |  |  |  |  | 620 |
Accounts payable and other liabilities |  |  |  |  |  | 5,910 |
Net assets acquired |  |  |  |  |  | 60,067 |
Medtronic MicroFrance | Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Intangible assets |  |  |  |  |  | 4,580 |
Medtronic MicroFrance | Trade names |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Intangible assets |  |  |  |  |  | 11,990 |
Medtronic MicroFrance | Customer Relationships |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Intangible assets |  |  |  |  |  | $ 18,130 |
Confluent Surgical, Inc. |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Property, plant, and equipment |  |  |  |  | 438 |  |
Goodwill |  |  |  |  | 105,331 |  |
Total assets acquired |  |  |  |  | 349,981 |  |
Other non-current liabilities |  |  |  |  | 731 |  |
Prepaid expenses |  |  |  |  | 4,000 |  |
Contingent supply liability |  |  |  |  | 5,891 |  |
Deferred tax liability |  |  |  |  | 87,464 |  |
Deferred tax assets - long term |  |  |  |  | 12 |  |
Net assets acquired |  |  |  |  | 255,895 |  | $ 255,900
Confluent Surgical, Inc. | Developed Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Intangible assets |  |  |  |  | 239,800 |  |
Confluent Surgical, Inc. | Other |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Intangible assets |  |  |  |  | 400 |  |
Tarsus Medical, Inc. |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Payments to Acquire Businesses, Gross |  |  |  | $ 4,700 |  |  |
Cash |  |  |  | 85 |  |  |
Goodwill |  |  |  | 116 |  |  |
Total assets acquired |  |  |  | 6,928 |  |  |
Prepaid expenses |  |  |  | 13 |  |  |
Accounts payable and other liabilities |  |  |  | 111 |  |  |
Deferred tax liability |  |  |  | 2,152 |  |  |
Deferred tax assets - long term |  |  |  | 1,334 |  |  |
Net assets acquired |  |  |  | 4,665 |  |  |
Tarsus Medical, Inc. | Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Intangible assets |  |  |  | 5,040 |  |  |
Tekmed |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Inventory |  |  |  |  | 1,143 |  |
Property, plant, and equipment |  |  |  |  | 669 |  |
Other current assets |  |  |  |  | 11 |  |
Goodwill |  |  |  |  | 9,665 |  |
Total assets acquired |  |  |  |  | 16,469 |  |
Accrued expenses and other liabilities |  |  |  |  | 753 |  |
Deferred tax liabilities |  |  |  |  | 1,564 |  |
Net assets acquired |  |  |  |  | 14,152 |  |
Tekmed | Supplier Contracts |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Intangible assets |  |  |  |  | 4,981 |  |
Salto and Futura |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Payments to Acquire Businesses, Gross | $ 6,000 |  |  |  |  |  |
Inventory |  |  |  |  | 2,688 |  |
Property, plant, and equipment |  |  |  |  | 1,453 |  |
Total assets acquired |  |  |  |  | 7,811 |  |
Deferred tax liabilities |  |  |  |  | 700 |  |
Net assets acquired |  |  |  |  | 7,111 |  |
Salto and Futura | Ankle product family |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Intangible assets |  |  |  |  | $ 3,210 |  |
Wtd. Avg. Life: |  |  |  |  | 11 years |  |
Salto and Futura | Toe product family |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Intangible assets |  |  |  |  | $ 460 |  |
Wtd. Avg. Life: |  |  |  |  | 10 years |  |
In-process research and development | Metasurg |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
In-process research and development |  |  |  |  | $ 190 |  |
In-process research and development | Tarsus Medical, Inc. |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
In-process research and development |  |  |  | $ 340 |  |  |
Maximum | TEI Biosciences Inc and TEI Medical Inc. | Developed Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  | 16 years |  |
Maximum | TEI Biosciences Inc and TEI Medical Inc. | Contractual Relationships |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  | 14 years |  |
Maximum | Metasurg | Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  | 14 years |  |
Maximum | Medtronic MicroFrance | Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  |  | 16 years |
Maximum | Medtronic MicroFrance | Trade names |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  |  | 20 years |
Maximum | Medtronic MicroFrance | Customer Relationships |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  |  | 16 years |
Maximum | Confluent Surgical, Inc. | Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  |  | 20 years |
Maximum | Tarsus Medical, Inc. | Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  | 14 years |  |  |
Maximum | Tekmed | Supplier Contracts |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  | 13 years |  |
Minimum | TEI Biosciences Inc and TEI Medical Inc. | Developed Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  | 14 years |  |
Minimum | TEI Biosciences Inc and TEI Medical Inc. | Contractual Relationships |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  | 11 years |  |
Minimum | Metasurg | Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  | 8 years |  |
Minimum | Medtronic MicroFrance | Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  |  | 15 years |
Minimum | Medtronic MicroFrance | Customer Relationships |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  |  | 12 years |
Minimum | Confluent Surgical, Inc. | Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  |  | 3 years |
Minimum | Tarsus Medical, Inc. | Technology |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  | 10 years |  |  |
Minimum | Tekmed | Supplier Contracts |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Wtd. Avg. Life: |  |  |  |  | 2 years |  |

X
- Definition Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Expenses and Other Liabilities + References No definition available. + Details
Name: | iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccruedExpensesandOtherLiabilities
Namespace Prefix: | iart_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred tax liabilities + References No definition available. + Details
Name: | iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDeferredtaxliabilities
Namespace Prefix: | iart_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Income Tax Receivable + References No definition available. + Details
Name: | iart_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIncomeTaxReceivable
Namespace Prefix: | iart_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275 + Details
Name: | us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of assets acquired at the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 55 -Paragraph 37 -URI http://asc.fasb.org/extlink&oid=35744172&loc=d3e2207-128464 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of deferred tax asset attributable to deductible temporary differences and carryforwards that are expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssetsNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of deferred tax liability attributable to taxable temporary differences due after one year or the normal operating cycle, if longer, assumed at the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 55 -Paragraph 37 -URI http://asc.fasb.org/extlink&oid=35744172&loc=d3e2207-128464 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of inventory recognized as of the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 55 -Paragraph 37 -URI http://asc.fasb.org/extlink&oid=35744172&loc=d3e2207-128464 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of property, plant, and equipment recognized as of the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 55 -Paragraph 37 -URI http://asc.fasb.org/extlink&oid=35744172&loc=d3e2207-128464 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266 + Details
Name: | us-gaap_Goodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_TEIBiosciencesIncandTEIMedicalInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_MetasurgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_MedtronicMicroFranceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_ConfluentSurgicalInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_TarsusMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_TekmedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_IntegraSupplierContractMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_SaltoandFuturaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_AnkleProductFamilyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=iart_ToeProductFamilyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |